Vanos
Vanos (fluocinonide) Cream, 0.1% is a high-potency topical corticosteroid. It is formulated to reduce swelling, redness, itching, and inflammation associated with severe skin conditions such as psoriasis and eczema.
Dosage by Body Weight
Apply a thin layer to the affected skin areas once or twice daily as directed by your doctor. Rub in gently. Do not use for more than 2 consecutive weeks, and do not exceed 60 grams per week unless directed by a physician.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy of Vanos cream have not been established in pediatric patients. Use is generally restricted to patients 12 years of age and older due to risk of HPA axis suppression.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Topical corticosteroids can be absorbed systemically in infants and young children, leading to potential side effects.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Not indicated for children in this weight range due to high systemic exposure risk.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Avoid use unless specifically prescribed and monitored closely by a specialist.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness in pediatric patients under 12 years of age have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Safety and efficacy of Vanos cream have not been established in pediatric patients. Use is generally restricted to patients 12 years of age and older due to risk of HPA axis suppression. |
| 5-7 kg | Not recommended | Do not use | Topical corticosteroids can be absorbed systemically in infants and young children, leading to potential side effects. |
| 8-10 kg | Not recommended | Do not use | Not indicated for children in this weight range due to high systemic exposure risk. |
| 11-15 kg | Not recommended | Do not use | Avoid use unless specifically prescribed and monitored closely by a specialist. |
| 16-20 kg | Not recommended | Do not use | Safety and effectiveness in pediatric patients under 12 years of age have not been established. |
Formulation
Cream
Purpose
Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and plaque psoriasis
Generic Name
FluocinonideScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.